| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/19/2009 | CA2687332A1 Pyrrolopyridine derivatives and their use as bace inhibitors |
| 02/18/2009 | EP2025676A1 Novel indazole derivative having spiro ring structure in side chain |
| 02/18/2009 | EP2025666A2 Thiolalkyl benzoic acid derivatives |
| 02/18/2009 | EP2024368A2 6,7,8,9-tetrahydro-5h-pyrimido[4,5-d]azepin-4-yl]-amine derivatives as modulators of trpv1 for the treatment of pain |
| 02/18/2009 | EP2024363A1 N-oxides of pyridylmethylpiperazine and -piperidine derivatives |
| 02/18/2009 | EP2024360A2 Substituted pyrazolopyrimidines |
| 02/18/2009 | EP2024359A1 Compounds that are agonists of muscarinic receptors and that may be effective in treating pain, alzheimer's decease and/or schizophrenia |
| 02/18/2009 | EP2023958A1 Pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 02/18/2009 | EP2023949A2 Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics |
| 02/18/2009 | EP2023928A1 Coated pharmaceutical product for intraoral delivery of nicotine comprising trometamol as buffering agent |
| 02/18/2009 | EP2023921A1 Inhibitor of adenylyl cyclase for treating a disorder of the circadian rhythm |
| 02/18/2009 | EP2023911A2 Compounds a-r-x for the manufacture of pharmaceutical preparations |
| 02/18/2009 | EP2023909A2 Muscarinic agonists to treat impulse control disorders |
| 02/18/2009 | EP2023747A2 3,5-dihydroxy-2,4-cyclohexadienones and their derivatives, dietary compositions and fortified food containing them and their uses |
| 02/18/2009 | EP2023735A2 Use of nogo receptor-1 (ngr1) antagonists for promoting oligodendrocyte survival |
| 02/18/2009 | EP2023729A2 Organic compounds |
| 02/18/2009 | EP1928833B1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 02/18/2009 | EP1899333B1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 02/18/2009 | EP1831172B1 Substituted carbamic acid quinolin-6-yl esters useful as acetylcholinesterase inhibitors |
| 02/18/2009 | EP1773740B1 Neurologically-active compounds |
| 02/18/2009 | EP1758907B1 Diphenylimidazopyrimidine and -imidazole amines as inhibitors of b-secretase |
| 02/18/2009 | EP1727801B1 Piperazines useful for treating pain |
| 02/18/2009 | EP1699465B1 The use of hydrocortisone to treat depression |
| 02/18/2009 | EP1636260B1 Improved secretion of neublastin |
| 02/18/2009 | EP1614684B1 Diamine derivative, production process, and antioxidizing drug |
| 02/18/2009 | EP1569635B1 Use of carnitines for the prevention and/or treatment of disorders caused by the andropause |
| 02/18/2009 | EP1513493B1 Analgesics |
| 02/18/2009 | EP1497265B1 Compounds having affinity at 5ht2c receptor and use thereof in therapy |
| 02/18/2009 | EP1399431B1 Novel nitriles useful as reversible inhibitors of cysteine proteases |
| 02/18/2009 | EP1392298B1 Fused heterocyclic compounds |
| 02/18/2009 | EP1360178B1 Novel heterocyclic analogs of diphenylethylene compounds |
| 02/18/2009 | EP1208097B1 Substituted oxoazaheterocyclyl compounds |
| 02/18/2009 | EP1028945B9 Substituted pyridine compounds as anti-inflammatory agents |
| 02/18/2009 | EP0842143B3 2-(4-substituted)-benzylamino-2-methyl-propanamide derivatives |
| 02/18/2009 | CN101371142A Method of diagnosis and method of treatment |
| 02/18/2009 | CN101370809A Novel diazabicycloalkane derivatives and their medical use |
| 02/18/2009 | CN101370807A Aryl-isoxazol-4-yl-imidazo[1,2-a]pyridine useful for the treatment of alzheimer's disease via GABA receptors |
| 02/18/2009 | CN101370782A Alkylsulphonamide quinolines |
| 02/18/2009 | CN101370780A Organic compound |
| 02/18/2009 | CN101370775A Sulfonyl substituted 1H-indoles as ligands for the 5-hydroxytryptamine receptors |
| 02/18/2009 | CN101370771A Dibenzene derivatives as calcium channel blockers |
| 02/18/2009 | CN101370507A Therapeutic drug for traumatic neural disease (disorder) and/or motor function disorder |
| 02/18/2009 | CN101370503A Use of a combination of morphine and at least one opiate antagonist for treatment of opiate dependency and for prevention of non-oral opiate abuse in opiate addicts |
| 02/18/2009 | CN101370500A Use of 2-imidazoles for the treatment of CNS disorders |
| 02/18/2009 | CN101370499A Combination of ACHE inhibitor and 5-HT6 antagonist for the treatment of cognitive dysfunction |
| 02/18/2009 | CN101370495A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder |
| 02/18/2009 | CN101370494A Use of benzo-fused heterocycle sulfamide derivatives for the treatment of substance abuse and addiction |
| 02/18/2009 | CN101370396A Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 02/18/2009 | CN101370395A Composition comprising polyunsaturated fatty acids for improving membrane composition |
| 02/18/2009 | CN101367874A Anti-amyloid antibodies, compositions, methods and uses |
| 02/18/2009 | CN101367834A Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol |
| 02/18/2009 | CN101367757A Preparation method for (S)-4-hydroxyl-2-oxo-1-pyrrolidine ethanamide |
| 02/18/2009 | CN101366929A Capsule for expelling toxin and giving up smoking |
| 02/18/2009 | CN101366923A Chewing gum for preventing and controlling senile dementia |
| 02/18/2009 | CN101366918A Preparation method of medicinal granules for clearing fat, reducing blood pressure and pacifying the mind |
| 02/18/2009 | CN101366906A Chinese medicinal composition of medicine pillow for assisting sleep |
| 02/18/2009 | CN101366888A Antalgica wine |
| 02/18/2009 | CN101366874A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366873A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366872A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366871A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366870A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366869A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366868A Medicament composition for preventing birth defect, improving memory and intelligence |
| 02/18/2009 | CN101366867A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366866A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366865A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366864A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366863A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366862A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366860A Jiaomei oral liquid for benefiting sleep and removing speckle |
| 02/18/2009 | CN101366842A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366841A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366840A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366839A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366838A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366837A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366836A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366835A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366834A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366833A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366832A Method for preparing compound cavel capsule |
| 02/18/2009 | CN101366824A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366823A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366822A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366821A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366820A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366819A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366818A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366817A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366816A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366815A Medicament composition for preventing birth defect and improving memory |
| 02/18/2009 | CN101366813A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366812A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366811A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366810A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366809A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366808A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366807A Medicament composition for preventing birth defection and improving memory |
| 02/18/2009 | CN101366805A Medicament composition for preventing birth defect and improving memory and intelligence |